CHADS2 score

Revision as of 19:02, 31 December 2009 by C Michael Gibson (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Otheruses2

WikiDoc Resources for CHADS2 score

Articles

Most recent articles on CHADS2 score

Most cited articles on CHADS2 score

Review articles on CHADS2 score

Articles on CHADS2 score in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CHADS2 score

Images of CHADS2 score

Photos of CHADS2 score

Podcasts & MP3s on CHADS2 score

Videos on CHADS2 score

Evidence Based Medicine

Cochrane Collaboration on CHADS2 score

Bandolier on CHADS2 score

TRIP on CHADS2 score

Clinical Trials

Ongoing Trials on CHADS2 score at Clinical Trials.gov

Trial results on CHADS2 score

Clinical Trials on CHADS2 score at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CHADS2 score

NICE Guidance on CHADS2 score

NHS PRODIGY Guidance

FDA on CHADS2 score

CDC on CHADS2 score

Books

Books on CHADS2 score

News

CHADS2 score in the news

Be alerted to news on CHADS2 score

News trends on CHADS2 score

Commentary

Blogs on CHADS2 score

Definitions

Definitions of CHADS2 score

Patient Resources / Community

Patient resources on CHADS2 score

Discussion groups on CHADS2 score

Patient Handouts on CHADS2 score

Directions to Hospitals Treating CHADS2 score

Risk calculators and risk factors for CHADS2 score

Healthcare Provider Resources

Symptoms of CHADS2 score

Causes & Risk Factors for CHADS2 score

Diagnostic studies for CHADS2 score

Treatment of CHADS2 score

Continuing Medical Education (CME)

CME Programs on CHADS2 score

International

CHADS2 score en Espanol

CHADS2 score en Francais

Business

CHADS2 score in the Marketplace

Patents on CHADS2 score

Experimental / Informatics

List of terms related to CHADS2 score

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

CHADS Score or CHADS2 Score is an clinical prediction rule for estimating the risk of stroke in patients with atrial fibrillation (AFIB), a common and usually benign heart arrythmia. It is used to determine the degree of anticoagulation therapy required,[1] since AFIB can cause the stasis of blood in the heart chambers, leading to the formation of a mural thrombus that can dislodge into the blood flow, reaching the brain and causing a stroke. A high CHADS score corresponds to a greater risk, and vice-versa. The CHADS/CHADS2 algorithm was validated by a cohort study published in JAMA in 2001 using 1,733 Atrial fibrillation patients tracked through Medicare claims.[2]

Algorithm

The CHADS/CHADS2 algorithm is as follows:[3]

C: Congestive heart failure = 1 point
H: Hypertension (systolic >160 mmHg) = 1 point
A: Age >75 years = 1 point
D: Diabetes = 1 point
S: Prior Transient ischemic attack or Stroke = 2 points

Risk of Stroke

According to the findings of the JAMA study, the risk of stroke as a percentage per year is:

Score Risk of Stroke Per Year 95% CIs from JAMA Study
0 1.9%
1 2.8%
2 4.0%
3 5.9%
4 8.5%
5 12.5%
6 18.2%

Recommendations for Anticoagulation

The following treatment strategies were recommended by the authors of theJAMA and Circulation articles:

Score Risk Anticoagulation Therapy Considerations
0 Low Aspirin 325 mg/day most likely to offer benefit, although lower doses may be similarly efficacious
1-2 Moderate Aspirin or Warfarin Raise INR to 2.0-3.0, depending on factors such as patient preference
3+ High Warfarin Raise INR to 2.0-3.0, unless contraindicated (e.g., history of falls, clinically significant GI bleeding, inability to obtain regular INR screening)

Criticism of CHADS

The main criticism of the CHADS/CHADS2 scoring system is that someone with atrial fibrillation and a previous history of stroke, but no other risk factors (i.e. CHADS2 Score = 2), is only classified as moderate risk, whereas that person is in fact at high risk of another stroke.

References

  1. Gage BF, van Walraven C, Pearce L; et al. (2004). "Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin". Circulation. 110 (16): 2287&ndash, 92. doi:10.1161/01.CIR.0000145172.55640.93. PMID 15477396.
  2. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001). "Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation". JAMA. 285 (22): 2864–70. PMID 11401607.
  3. "Risk of Stroke with AF". VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. Retrieved 2007-09-14.

Template:WikiDoc Sources